Navitas Semiconductor Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
05 juin 2023 16h05 HE
|
Navitas Semiconductor Corporation
TORRANCE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor Corporation (Nasdaq: NVTS) today announced, in connection with its previously announced public offering of 10,000,000 shares...
Btab Ecommerce Group, Inc. (formerly American Seniors Association Holding Group, Inc.) Announces Name Change and OTC Markets Ticker Symbol Change
05 juin 2023 05h03 HE
|
Btab Group
SYDNEY, Australia, June 05, 2023 (GLOBE NEWSWIRE) -- Btab Ecommerce Group, Inc., a Georgia Corporation (the “Company”), announced that at the open of market trading today, June 5, 2023, its trading...
Chijet Motor Company Listed on NASDAQ
02 juin 2023 15h01 HE
|
Chijet Motor Company, Inc.
NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) -- Chijet Motor Company, Inc. (the "Company" or "Chijet"), a developer of next-generation electric vehicles, was officially listed on NASDAQ on June 2, 2023...
Identity and Access Management Software Provider BIO-key Names Seasoned Financial Services Executive Cameron E. Williams to its Board of Directors
02 juin 2023 08h01 HE
|
BIO-key International, Inc.
WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring...
Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference
01 juin 2023 07h57 HE
|
Pasithea
PALO ALTO, Calif. and MIAMI, June 01, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research,...
atai Life Sciences to Participate in Upcoming June Investor Conferences
01 juin 2023 06h59 HE
|
atai Life Sciences
NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health...
Structure Therapeutics to Present at Jefferies Healthcare Conference
31 mai 2023 16h30 HE
|
Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, May 31, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule...
Minutes from Annual General Meeting 2023
26 mai 2023 12h07 HE
|
Hypefactors A/S
Copenhagen, May 26, 2023 (GLOBE NEWSWIRE) -- Announcement no. 6-2023 On 26 May 2023, at 16:00, the ordinary annual general meeting 2023 of Hypefactors A/S was conducted at the company’s address,...
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity
25 mai 2023 16h30 HE
|
Structure Therapeutics Inc.
12-week Phase 2a and Phase 1b multiple ascending dose (MAD) topline results expected to be announced in latter half of fourth quarter 2023 Ethnobridging study initiated in Japanese individuals and...
SHAREHOLDER ALERT: Morris Kandinov Investigating LTCH, LFST, BRY, and DNA; Shareholders are Encouraged to Contact the Firm
24 mai 2023 09h00 HE
|
Morris Kandinov, LLP
SAN DIEGO, May 24, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Latch, Inc., LifeStance Health Group, Inc., Berry...